Skip to main content
. 2020 May 27;6(2):42. doi: 10.3390/ijns6020042

Table 1.

All recalls, true positive cases, incidences during and before screening, false positive cases, missed cases, and PPV values during the entire reporting period. Within parenthesis are listed the corresponding numbers if counting babies with confirmed vitamin B12 deficiency as false positive. N/A stands for not applicable.

Group Disease All Recalls True Positive Cases Incidence Incidence before Screening False Positive Cases Missed Cases PPV
Amino acidemias HCY 15 3 1:330,000 1:265,000 12 - 20%
MSUD 20 9 1:110,000 1:265,000 11 - 45%
PKU 77 74 2 1:14,000 N/A 3 - 96%
Carnitine disorders CACT/CPT2 14 3 3 1:330,000 N/A 11 2 CPT2 6 21%
CUD 107 13 1:80,000 N/A 94 5 - 12%
CPT1 6 5 1:200,000 N/A 1 - 83%
Fatty acid oxidation defects LCHAD 14 13 1:80,000 1:92,000 1 - 93%
MAD 39 5 1:170,000 N/A 34 - 15%
MCAD 67 59 1:17,000 1:235,000 8 - 88%
VLCAD 46 24 1:42,000 1:1,060,000 22 - 52%
Organic acidurias BKT 2 2 1:500,000 N/A 0 - 100%
GA1 31 9 1:110,000 1:235,000 22 - 29%
IVA 18 6 1:170,000 1:530,000 12 - 33%
MMA/PA 165 63 (15) 4 1:16,000 (1:67,000) N/A (1:118,000) 102 (150) 1 PA 7 38% (9%)
TYR 10 9 1:110,000 N/A 1 - 90%
Urea cycle disorders ARG 4 2 1:500,000 1:265,000 2 - 50%
ASA 1 5 3 1:330,000 N/A 2 1 ASA 8 60%
CIT 1 25 9 1:110,000 1:2,120,000 16 - 36%
Total 665 311 (263) 1:3200 (1:3800) N/A 354 (402) 4 47% (40%)

1 We could not separate ASA and CIT at point of recall before 2015. 2 Three had 6-pyruvoyl-tetrahydropterin synthase deficiency. 3 One CACT and two CPT2, one of which also had MAD. 4 Four methylmalonyl-coenzyme A mutase deficiency, one cobalamin A deficiency, three cobalamin C deficiency, seven PA and 48 B12 deficiency. 5 Six were due to confirmed maternal CUD and six due to confirmed maternal carnitine-lowering medication. 6 One was from 2011, the other was from 2012. 7 From 2014. 8 From 2016.